Improved yields of factor VIII from heparinized plasma.
The Factor VIII procoagulant activity in plasma, cryoprecipitate, and their polyethylene glycol (PEG) precipitates is markedly increased if blood is collected into heparin rather than into citrate phosphate dextrose (CPD). There is a 34% increase in the initial level of the Factor VIII activity in the heparinized plasma with 78% of this initial activity (184 U) recovered in the cryoprecipitated. As well, the stability of the Factor VIII activity is improved: after 24 h of incubation at 22 degrees C, 99% of the initial activity is retained in heparinized plasma whereas only 64% remains in CPD plasma. The cryoprecipitate prepared from heparinized plasma is equally stable after 24 h. The PEG concentrate prepared from the cryoprecipitate of heparinized plasma is increased to 128 U compared to only 54 U from CPD plasma. Relative recoveries were 531 U/l for heparinized plasma versus 215 U/l for CPD plasma. This represents a 147% increase in yield.
D000925:Anticoagulants / Q000494:pharmacology; D001793:Blood Preservation; D001800:Blood Specimen Collection; D011232:Chemical Precipitation; D002951:Citrates; D003450:Cryoglobulins; D005169:Factor VIII / Q000302:isolation & purification*; D005947:Glucose; D006493:Heparin / Q000097:blood*; D006801:Humans; D008297:Male; D010710:Phosphates; D011092:Polyethylene Glycols / Q000494:pharmacology
D000925:Anticoagulants; D002951:Citrates; D003450:Cryoglobulins; D010710:Phosphates; D011092:Polyethylene Glycols; D005169:Factor VIII; D006493:Heparin; D005947:Glucose